CINGULATE INC
CING · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $4.94
- Today’s Low
- $4.67
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.81
- Previous Close
- $4.84
- Volume
- 30.15K
- Market Cap
- $70.38M
- P/E Ratio
- --
- EPS
- $-3.68
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1901 WEST 47TH PLACE, KANSAS CITY, KS, UNITED STATES, 66205
- Country
- US
- Listing Date
- 2021-10-07
- Fiscal Year End
- December
- Shares Outstanding
- 13.47M
- CIK
- 0001862150
- Website
- www.cingulate.com
Cingulate Inc., a clinical-stage biopharmaceutical company, is focused on developing candidate products for the treatment of neurobiological and central nervous system disorders. The company is headquartered in Kansas City, Kansas.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$5.41M
2026-03-31
$7.92M
2025-12-31
$5.58M
2025-09-30
$5.99M
Net Income
2026-06-30
-$5.87M
2026-03-31
-$9.31M
2025-12-31
-$6.27M
2025-09-30
-$7.34M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.45
2026-03-31
$-0.95
2025-12-31
$-0.84
2025-09-30
$-1.35
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.63M
2026-03-31
-$7.8M
2025-12-31
-$5.46M
2025-09-30
-$5.88M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $5.41M | $7.92M | $5.58M | $5.99M |
| Net Income | -$5.87M | -$9.31M | -$6.27M | -$7.34M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.45 | $-0.95 | $-0.84 | $-1.35 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.63M | -$7.8M | -$5.46M | -$5.88M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.